ArticleMolecular therapy : the journal of the American Society of Gene Therapy2016

CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease.

John Marshall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.